In vitro activity of the synthetic lipopeptide PAL-Lys-Lys-NH2 alone and in combination with antifungal agents against clinical isolates of Cryptococcus neoformans

Has Antifungal Susceptibility Testing Come of Age?

John Rex, Michael A. Pfaller · Clinical Infectious Diseases · 2002 · 363 citations

Veterinary Medicine, Infectious Diseases, Pharmacology +15

<i>Cryptococcus neoformans</i>Infection in Organ Transplant Recipients: Variables Influencing Clinical Characteristics and Outcome

Shahid Husain, Marilyn M. Wagener, Nina Singh · Emerging infectious diseases · 2001 · 311 citations · Full text

Life Sciences, Immunology, Infectious Diseases +14

Epidemiology of HIV-associated cryptococcosis in France (1985–2001)

Françoise Dromer, Simone Mathoulin‐Pélissier, Arnaud Fontanet et al. · AIDS · 2004 · 200 citations

Veterinary Medicine, Infectious Diseases, Disease Surveillance +16

A New Group of Antifungal and Antibacterial Lipopeptides Derived from Non-membrane Active Peptides Conjugated to Palmitic Acid

Dorit Avrahami, Yechiel Shai · Journal of Biological Chemistry · 2004 · 168 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +16

Identification of Patients with Acute AIDS-Associated Cryptococcal Meningitis Who Can Be Effectively Treated with Fluconazole: The Role of Antifungal Susceptibility Testing

Mallory D. Witt, Robert Lewis, Robert A. Larsen et al. · Clinical Infectious Diseases · 1996 · 137 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +17